Back to Results
First PageMeta Content
Medicine / Chemistry / Tacrolimus / Pimecrolimus / Pharmacology / Atopic dermatitis / Atopy / Medical prescription / Astellas Pharma / Immunosuppressants / Macrolides / Type 1 hypersensitivity


Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology
Add to Reading List

Open Document

File Size: 298,48 KB

Share Result on Facebook

Company

IMS Health / Epidemiology Office / D. Drug Use Data / Astellas Pharma US Inc. / Novartis Pharmaceutical Corp. / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

non-retail channels / retail settings / retail / retail and non-retail channels / food stores / outpatient retail pharmacies / non-retail settings / medicinal products / outpatient retail settings / /

MedicalCondition

Other Atopic Dermatitis / /

MedicalTreatment

Osteopathy / /

OperatingSystem

OSE / /

Organization

PA NP / SDI Total Patient Tracker / OIASI Office / PA IM / Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation / Epidemiology office of Surveillance and Epidemiology Subject / office of Surveillance / office of Pediatric Therapeutics / Pediatric and Maternal Health Team Office / FDA / Research office of Surveillance and Epidemiology Date / Epidemiology office of Surveillance / /

Person

Felicia Collins / Lisa L. Mathis / M. Dianne Murphy / Laura Governale / Patty Greene / /

Position

Analyst Division / contractor / Director / Commissioner / EXECUTIVE / Physician / Medical Officer / Analyst / General / Epidemiology.** CONTENTS EXECUTIVE / SDI Physician / Leader Division / /

Product

Protopic / Elidel / Protopic® (tacrolimus) ointment / /

SocialTag